banner
HCV protease inhibitor Glecaprevir, Purity ≥98%

Cat. No.: X24-07-ZQ078

HCV protease inhibitor Glecaprevir, Purity ≥98%

Synonym: 1365970-03-1; HCV protease inhibitor; ABT-493; ABT493; ABT 493; A-1282576; A1282576; A 1282576

  • CAS Number: 1365970-03-1
  • Compound CID: 66828839
Product Size
2 mg; 5 mg; 10 mg; 50 mg
Price
Datasheet
MSDS
Properties
Description
Glecaprevir, soluble in DMSO, targets and inhibits the function of the hepatitis C virus protease enzyme.
Molecular Weight
838.87
Molecular Formula
C38H46F4N6O9S
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 99 mg/mL (118.01 mM)
Identity
Confirmed by NMR/HPLC/MS.
Applications
Glecaprevir is researched in the context of its action as an NS3/4A protease inhibitor against HCV, aiding studies on viral life cycle interference and treatment optimization.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0